Patients receiving hemodialysis in Bahrain face a high risk of all-cause mortality following tunnel-related Staphylococcus aureus infections, according to a retrospective cohort study published by Cureus.
Researchers analyzed 44 infection episodes across government hospitals between January 2023 and December 2025, finding an overall mortality rate of 43.2%.
The study, which examined data from 44 infection episodes, found that 24 cases (54.5%) were catheter-related bloodstream infections (CRBSI), while 20 (45.5%) were categorized as exit-site infections. Despite the high overall mortality rate, the 30-day mortality was 2.3%, suggesting that deaths occurred later in the patient follow-up period.
The cohort had a mean age of 53.8 years, with 70.5% of episodes occurring in male patients. Methicillin-resistant Staphylococcus aureus (MRSA) accounted for 15 of the 44 episodes (34.1%). Among these MRSA cases, 11 (73.3%) were bloodstream infections, whereas 44.8% of methicillin-susceptible Staphylococcus aureus (MSSA) episodes were bloodstream-related.
Researchers evaluated potential mortality predictors, including diabetes mellitus, which was present in 77.3% of episodes, and peripheral vascular disease (PVD), documented in 47.7%.
While point estimates indicated an increased risk associated with these conditions and prior antibiotic exposure, multivariable binary logistic regression showed no statistically significant association with mortality for these factors.
The study authors said that with only 6.3 events per variable, the findings should be considered hypothesis-generating. They concluded that prospective multicenter studies across the Gulf Cooperation Council region are necessary to validate these results and better inform infection control protocols for hemodialysis patients.